Filing exhibits
- 8-K Current report
- 10.1 September 15, 2022, License and Distribution Agreement by and Between AXIM Biotechnologies, Inc. and Versea Ophthalmics, LLC
- 99.1 Company to Sell, Distribute AXIM’s Readers and Three Proprietary Tests Designed for Diagnosis of Dry Eye Disease Globally Through New Agreement
- Download Excel data file
- View Excel data file
Table of Contents